ventilated associated pneumonia. J15 Bacterial pneumonia, not elsewhere classified
Conditions
Interventions
Eucalyptus mouthwash group 0.01 percent.
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Obtaining informed consent from the patient's guardian Age 18-70 years No history of lung disease No prohibitions on performing oral hygiene care Not having diseases that weaken the immune system No history of allergy to herbal ingredients No history of chemotherapy Under mechanical ventilation for less than 48 hours
Exclusion criteria
Exclusion criteria: Presence of any allergic reactions such as fever, urticaria(hives) Replacement of the endotracheal tube or extubation of the patient before the completion of the study Transition to another section Informed consent from the guardian to continue the study. Performing tracheostomy before completing the intervention. Incidence of pulmonary aspiration during the study death of the patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oral health. Timepoint: The effect of chlorhexidine and eucalyptus mouthwashes on oral health and ventilator-associated pneumonia will be measured at the beginning of the intervention and on days 3 and 5. Method of measurement: beak oral assesment.;Ventilated associated pneumonia. Timepoint: The effect of chlorhexidine and eucalyptus mouthwashes on ventilator-associated pneumonia will be measured at the beginning of the intervention and on days 3 and 5. Method of measurement: clinical pulmonary infection scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahmoud Bakhshi
Mashhad University of Medical Sciences
Outcome results
None listed